| Guidelines for radioiodine therapy of differentiated thyroid cancer M Luster, SE Clarke, M Dietlein, M Lassmann, P Lind, WJG Oyen, ... European journal of nuclear medicine and molecular imaging 35, 1941-1959, 2008 | 866 | 2008 |
| EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology B Hesse, K Tägil, A Cuocolo, C Anagnostopoulos, M Bardiès, J Bax, ... European journal of nuclear medicine and molecular imaging 32, 855-897, 2005 | 678 | 2005 |
| Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized … F Pacini, PW Ladenson, M Schlumberger, A Driedger, M Luster, RT Kloos, ... The Journal of Clinical Endocrinology & Metabolism 91 (3), 926-932, 2006 | 575 | 2006 |
| 68Ga-and 177Lu-labeled PSMA I&T: optimization of a PSMA-targeted theranostic concept and first proof-of-concept human studies M Weineisen, M Schottelius, J Simecek, RP Baum, A Yildiz, S Beykan, ... Journal of Nuclear Medicine 56 (8), 1169-1176, 2015 | 562 | 2015 |
| Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or … H Hänscheid, M Lassmann, M Luster, SR Thomas, F Pacini, C Ceccarelli, ... Journal of Nuclear Medicine 47 (4), 648-654, 2006 | 412 | 2006 |
| EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT) C Kratochwil, WP Fendler, M Eiber, R Baum, MF Bozkurt, J Czernin, ... European journal of nuclear medicine and molecular imaging 46, 2536-2544, 2019 | 327 | 2019 |
| The new EANM paediatric dosage card M Lassmann, L Biassoni, M Monsieurs, C Franzius, F Jacobs, ... European journal of nuclear medicine and molecular imaging 34, 796-798, 2007 | 286 | 2007 |
| EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy M Lassmann, H Hänscheid, C Chiesa, C Hindorf, G Flux, M Luster European journal of nuclear medicine and molecular imaging 35, 1405-1412, 2008 | 267 | 2008 |
| EANM procedure guidelines for therapy of benign thyroid disease MPM Stokkel, D Handkiewicz Junak, M Lassmann, M Dietlein, M Luster European journal of nuclear medicine and molecular imaging 37, 2218-2228, 2010 | 261 | 2010 |
| First-in-human experience of CXCR4-directed endoradiotherapy with 177Lu-and 90Y-labeled pentixather in advanced-stage multiple myeloma with extensive intra-and extramedullary … K Herrmann, M Schottelius, C Lapa, T Osl, A Poschenrieder, H Hänscheid, ... Journal of nuclear medicine 57 (2), 248-251, 2016 | 251 | 2016 |
| rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review M Luster, F Lippi, B Jarzab, P Perros, M Lassmann, C Reiners, F Pacini Endocrine-Related Cancer 12 (1), 49-64, 2005 | 246 | 2005 |
| The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy L Strigari, M Konijnenberg, C Chiesa, M Bardies, Y Du, KS Gleisner, ... European journal of nuclear medicine and molecular imaging 41, 1976-1988, 2014 | 242 | 2014 |
| EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy F Giammarile, A Chiti, M Lassmann, B Brans, G Flux European journal of nuclear medicine and molecular imaging 35, 1039-1047, 2008 | 242 | 2008 |
| Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma LWT Alkureishi, Z Burak, JA Alvarez, J Ballinger, A Bilde, AJ Britten, ... European journal of nuclear medicine and molecular imaging 36, 1915-1936, 2009 | 220 | 2009 |
| EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting M Lassmann, C Chiesa, G Flux, M Bardiès European journal of nuclear medicine and molecular imaging 38, 192-200, 2011 | 217 | 2011 |
| 68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT C Bluemel, M Krebs, B Polat, F Linke, M Eiber, S Samnick, C Lapa, ... Clinical nuclear medicine 41 (7), 515-521, 2016 | 216 | 2016 |
| Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging HJ Wester, U Keller, M Schottelius, A Beer, K Philipp-Abbrederis, ... Theranostics 5 (6), 618, 2015 | 189 | 2015 |
| Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5. 2008) and the 2010 North American consensus guidelines M Lassmann, ST Treves, ... European journal of nuclear medicine and molecular imaging 41, 1036-1041, 2014 | 184 | 2014 |
| Dose mapping after endoradiotherapy with 177Lu-DOTATATE/DOTATOC by a single measurement after 4 days H Hänscheid, C Lapa, AK Buck, M Lassmann, RA Werner Journal of Nuclear Medicine 59 (1), 75-81, 2018 | 170 | 2018 |
| Impact of 131I diagnostic activities on the biokinetics of thyroid remnants M Lassmann, M Luster, H Hänscheid, C Reiners Journal of Nuclear Medicine 45 (4), 619-625, 2004 | 170 | 2004 |
Christoph ReinersUniversity of Würzburg, GermanyVerified email at ukw.de
